What is microglia neurotoxicity (Not)?
Abstract
Microglia most likely appeared early in evolution as they are not only present in vertebrates, but are also found in nervous systems of various nonvertebrate organisms. Mammalian microglia are derived from a specific embryonic, self‐renewable myeloid cell population that is throughout lifetime not replaced by peripheral myeloid cells. These phylogenic and ontogenic features suggest that microglia serve vital functions. Yet, microglia often are described as neurotoxic cells, that actively kill (healthy) neurons. Since it is from an evolutionary point of view difficult to understand why an important and vulnerable organ like the brain should host numerous potential killers, we here review the concept of microglia neurotoxicity. On one hand it is discussed that most of our understanding about how microglia kill neurons is based on in vitro experiments or correlative staining studies that suffer from the difficulty to discriminate microglia and peripheral myeloid cells in the diseased brain. On the other hand it is described that a more functional approach by mutating, inactivating or deleting microglia is seldom associated with a beneficial outcome in an acute injury situation, suggesting that microglia are normally important protective elements in the brain. This might change in chronic disease or the aged brain, where; however, it remains to be established whether microglia simply lose their protective capacities or whether microglia become truly neurotoxic cells. GLIA 2014;62:841–854Keywords
This publication has 169 references indexed in Scilit:
- The CCL2‐CCR2 system affects the progression and clearance of intracerebral hemorrhageGlia, 2012
- Proteomic analysis of the anti‐inflammatory action of minocyclineProteomics, 2010
- Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challengeBrain, Behavior, and Immunity, 2010
- Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in miceNeurobiology of Disease, 2010
- Cell-specific roles of GRK2 in onset and severity of hypoxic-ischemic brain damage in neonatal miceBrain, Behavior, and Immunity, 2010
- Heterogeneity of Microglial Activation in the Innate Immune Response in the BrainJournal of Neuroimmune Pharmacology, 2009
- Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s diseaseActa Neuropathologica, 2009
- Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and agingGlia, 2009
- Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokinesBrain, Behavior, and Immunity, 2009
- Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammationExperimental Neurology, 2009